Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01XEQ
|
|||
| Former ID |
DCL000945
|
|||
| Drug Name |
R348
|
|||
| Indication | Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Terminated | [1] | |
| Company |
Rigel Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H11N
|
|||
| Canonical SMILES |
CCC1=C(C=CN=C1)C
|
|||
| InChI |
1S/C8H11N/c1-3-8-6-9-5-4-7(8)2/h4-6H,3H2,1-2H3
|
|||
| InChIKey |
JDQNYWYMNFRKNQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 529-21-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.